Published ahead of print on April 15, 2004, doi:10.1164/rccm.200305-659OC
Am. J. Respir. Crit. Care Med., Volume 170, Number 2, July 2004, 141-147
A more recent version of this article appeared on July 15, 2004
Submitted on May 15, 2003
Accepted on April 9, 2004
Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Mononocytes in Asthma
Borja G Cosio1, Buphinder Mann1, Kazuhiro Ito1, Elen Jazrawi1, Peter J Barnes1, K Fan Chung1, and Ian M Adcock1*
1 Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College Faculty of Medicine, London, United Kingdom
* To whom correspondence should be addressed. E-mail: ian.adcock{at}ic.ac.uk.
Histone acetylation status is a key factor in the regulation of inflammatory gene transcription. We investigated the activity of histone acetylases (HAT) and deacetylases (HDAC) in alveolar macrophages (AM) and peripheral blood mononuclear cells (PBMCs) from asthmatic subjects and the effect of glucocorticoids. Bronchoalveolar lavage was performed in 10 patients with intermittent asthma, eight with persistent asthma and 10 healthy controls. PBMCs and granulocytes were isolated from 6 patients with mild and severe asthma, before and after a 7 day-course of prednisolone (30 mg daily). AM were isolated for HDAC assay or incubated with dexamethasone (1µM). HAT activity was increased (1.43±0.1 vs. 1.01±0.1 SU/10µg, p<0.05) and HDAC activity was reduced (3031±243 vs. 5004±164 AFU/10µg, p<0.001) in AM from asthmatics compared to control. Dexamethasone suppressed LPS-induced GM-CSF, TNFa and IL-8 release by 83±1%, 51±7% and 20±9% (p<0.001) respectively. This suppression was mimicked by nuclear factor-kB inhibition and IL-8 release was further reduced by the HDAC enhancer, theophylline (37±6%). Prednisolone increased HDAC activity in PBMCs from mild asthmatics. The increased inflammatory response in asthma may be due to reduced HDAC and enhanced HAT activity. Glucocorticoids and theophylline may down-regulate the inflammatory response by modulating HAT and HDAC activity and NF-kB activation.
Key words: inflammation, chromatin remodelling, theophylline, glucocorticoids, asthma
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Grabiec, S. Krausz, W. de Jager, T. Burakowski, D. Groot, M. E. Sanders, B. J. Prakken, W. Maslinski, E. Eldering, P. P. Tak, et al.
Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue
J. Immunol.,
March 1, 2010;
184(5):
2718 - 2728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Spears, I. Donnelly, L. Jolly, M. Brannigan, K. Ito, C. McSharry, J. Lafferty, R. Chaudhuri, G. Braganza, I. M. Adcock, et al.
Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study
Eur. Respir. J.,
May 1, 2009;
33(5):
1010 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Adenuga, H. Yao, T. H. March, J. Seagrave, and I. Rahman
Histone Deacetylase 2 Is Phosphorylated, Ubiquitinated, and Degraded by Cigarette Smoke
Am. J. Respir. Cell Mol. Biol.,
April 1, 2009;
40(4):
464 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Eur. Heart J.,
February 1, 2009;
30(3):
266 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Miller and S.-m. Ho
Epigenetic Studies Should Focus on Specific Cell Types
Am. J. Respir. Crit. Care Med.,
October 15, 2008;
178(8):
883 - 883.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Bhavsar, M Hew, N Khorasani, A Torrego, P J Barnes, I Adcock, and K F Chung
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma
Thorax,
September 1, 2008;
63(9):
784 - 790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Braganza, R. Chaudhuri, and N. C. Thomson
Review: Treating patients with respiratory disease who smoke
Therapeutic Advances in Respiratory Disease,
April 1, 2008;
2(2):
95 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Enya, H. Hayashi, T. Takii, N. Ohoka, S. Kanata, T. Okamoto, and K. Onozaki
The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1{alpha} in human melanoma cells
J. Leukoc. Biol.,
January 1, 2008;
83(1):
190 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam
An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease
Vascular Medicine,
November 1, 2007;
12(4):
299 - 309.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dombrowsky and S. Uhlig
Steroids and histone deacetylase in ventilation-induced gene transcription
Eur. Respir. J.,
November 1, 2007;
30(5):
865 - 877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-B. Nguyen, K. D. Callaghan, A. J. Ghio, D. J. Haile, and F. Yang
Hepcidin expression and iron transport in alveolar macrophages
Am J Physiol Lung Cell Mol Physiol,
September 1, 2006;
291(3):
L417 - L425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-R. Yang, A. S. Chida, M. R. Bauter, N. Shafiq, K. Seweryniak, S. B. Maggirwar, I. Kilty, and I. Rahman
Cigarette smoke induces proinflammatory cytokine release by activation of NF-{kappa}B and posttranslational modifications of histone deacetylase in macrophages
Am J Physiol Lung Cell Mol Physiol,
July 1, 2006;
291(1):
L46 - L57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, P. J. Barnes, and I. M. Adcock
Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}B suppression
J. Exp. Med.,
January 23, 2006;
203(1):
7 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ito, M. Ito, W. M. Elliott, B. Cosio, G. Caramori, O. M. Kon, A. Barczyk, S. Hayashi, I. M. Adcock, J. C. Hogg, et al.
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
May 12, 2005;
352(19):
1967 - 1976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Wu, M. Jin, and C. B. Marsh
Toward functional proteomics of alveolar macrophages
Am J Physiol Lung Cell Mol Physiol,
April 1, 2005;
288(4):
L585 - L595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, I. M. Adcock, and K. Ito
Histone acetylation and deacetylation: importance in inflammatory lung diseases
Eur. Respir. J.,
March 1, 2005;
25(3):
552 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|